Efficacy endpoints included the time-weighted average change from baseline in the WOMAC VA 3.0 Pain Subscale ( 100 mm Visual Analog Scale [ VAS ] ; primary endpoint ) , the WOMAC VA 3.0 Physical Function Subscale ( 100 mm VAS ) , and Patient Global Assessment of Disease Status ( PGAD ) ( 100 mm VAS ) .